Overview

Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Pulmonary Safety in Diabetics with T/I
Phase:
Phase 3
Details
Lead Sponsor:
Mannkind Corporation
Treatments:
Insulin
Insulin, Globin Zinc